Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Authors: Larissa I van der Windt, Job Klumper, Ruben G Duijnhoven, Marjolein Kok, Carrie Ris-Stalpers, Marjon A de Boer, Anton H van Kaam, Eva Pajkrt, Ben W Mol, Kate F Walker, Fionnuala M McAuliffe, Joris A van der Post, Carolien Roos, Martijn A Oudijk, Jelle M Schaaf, Jim van Eyck, H Marieke Knol, Marieke Sueters, Liesbeth H C J Scheepers, David P van der Ham, Judith O E H van Laar, Eline S A van den Akker, Ralph R Scholten, Nicolette van Gemund, Karlijn C Vollebregt, Harrie Visser, Sanne J Gordijn, Mireille N Bekker, Josje Langenveld
Institutions: Amsterdam UMC Location University of Amsterdam, Amsterdam Reproduction Development, Nederlandse Vereniging voor Obstetrie en Gynaecologie, Amsterdam UMC Location Vrije Universiteit Amsterdam, Emma Kinderziekenhuis, Amsterdam University Medical Centers, Monash University, University of Nottingham, Queen's Medical Centre, University College Dublin, National Maternity Hospital
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: ZonMw
OpenAlex ID: W4408111978